Trial intelligence / Profile preview

Wafermine PK Study (Simultaneous vs Sequential)

NCT02857361Phase 2Completed

Sponsor
iX Biopharma
Start
Jul 2016
Primary completion
Aug 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Wafermine in pain, sponsored by iX Biopharma. Started Jul 2016; status: completed.

02

Drugs

Wafermine
03

Conditions

pain

Beyond the preview

Go deeper on NCT02857361.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02857361.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call